Leukemia, Myelodysplasia, Transplantation
News
Sequential decitabine, idarubicin combo synergistic in AML
Credit: Rhoda Baer Researchers tested 5 anti-leukemia agents in combination with the methylation inhibitor decitabine and found that the...
News
One in four children with ALL misses maintenance doses
Credit: Bill Branson Forgetting to take medication is the number one reason for non-adherence to maintenance therapy in children with acute...
Conference Coverage
CAR T-cell therapy successfully used frontline as consolidation in CLL
©ASCO/Todd Buchanan CHICAGO—Infusion of autologous CD19-targeted chimeric antigen receptor (CAR)-modified T cells appears to have promising anti-...
News
‘Nanodaisies’ deliver drug cocktail to leukemia cells
Credit: PNAS Biomedical engineers have reported that daisy-shaped, nanoscale structures can deliver a cocktail of drugs directly to cancer cells...
News
Method reveals new targets of p53
Credit: A.T.
News
Team identifies mechanism of resistance in AML
Credit: Lance Liotta New research has revealed a mechanism of drug resistance in acute myeloid leukemia (AML) that may also occur in other...
News
ASCO 2014: Dr. David H. Henry’s top picks in leukemia research
News
Ibrutinib boosts survival of relapsed/refractory CLL
Major finding: One-year overall survival for patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (...
News
Mutation causes ibrutinib resistance in CLL
Credit: Rhoda Baer Researchers say they have identified a source of drug resistance in chronic lymphocytic leukemia (CLL). In a letter to The...
News
CHMP recommends ofatumumab for CLL
Credit: Linda Bartlett The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for...